Senior Director, Market Access at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

(Not explicitly listed in the job description)

Responsibilities

Lead the development of Legend’s market access strategies for CARVYKTI, pipeline assets and business development
Collaborate with Johnson & Johnson to contribute to integrated Market Access strategies
Provide key insights on market access, pricing and policy to cross-functional teams including alliance teams, clinical development, and corporate strategy, ensuring a holistic patient-centric access approach from the outset into the evolving clinical development programs
Review commercialization strategies and identify opportunities from an access, pricing and policy perspective and run Market Access research projects and lead value and access assessments to inform financial forecasting, business development, and strategy development
Develop and lead fully integrated access strategies
Support development of payer value propositions and supporting resources that reflect the holistic value of CARVYKTI’s innovation and enable early evidence and stakeholder engagement planning
Partner with Johnson & Johnson to optimize indication and geographic launch sequencing optimization plans by conducting comprehensive market access landscape assessments, early scientific advisory meetings, and development of reimbursement strategies
Educate internal stakeholders, business leaders, and cross-functional teams on existing or future access and reimbursement risks and opportunities for oncology assets in a dynamic healthcare system by seeking broad input and feedback to inform oncology portfolio strategies and priorities
Support innovative pricing, reimbursement and contracting solutions to overcome pricing and reimbursement challenges with a particular focus on novel-novel combination therapies
Anticipate market access and pricing trends and regulations, monitor competitor activities, identify strategic implications for Legend, and educate internal colleagues and senior business leaders on the market access and pricing environment
Leverage knowledge of the external policy and decision-maker environment to optimize evidence development and identify and highlight differentiation for our portfolio in close collaboration with cross-functional colleagues to identify systemic challenges to optimal pricing & reimbursement, and propose policy-based solutions
Plan, manage, and track consultants, agencies, vendor partnerships, and budget requirements, ensuring cost-effective execution of key activities within established timelines and budget constraints

Skills

Market Access

Pricing Strategy

Commercialization

Biotechnology

Cell Therapy

CAR-T

Strategic Collaboration

Policy Analysis

Business Development

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free